69 related articles for article (PubMed ID: 12697125)
1. [Hypermethylation status of blu gene in nasopharyngeal lymphoma].
Zhang XH; Jiang F; Li M; Xu Q; Li N; Tao Q; Gao ZF
Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):138-40. PubMed ID: 12697125
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients.
Ayadi W; Karray-Hakim H; Khabir A; Feki L; Charfi S; Boudawara T; Ghorbel A; Daoud J; Frikha M; Busson P; Hammami A
Anticancer Res; 2008; 28(4B):2161-7. PubMed ID: 18751390
[TBL] [Abstract][Full Text] [Related]
3. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
Tai YC; Kim LH; Peh SC
Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of suppressive roles of BLU gene at 3p21.3 in nasopharyngeal carcinoma].
Liu XQ; Pan ZG; Li MZ; Jiang JH; Fu J; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Feb; 22(2):128-35. PubMed ID: 12600284
[TBL] [Abstract][Full Text] [Related]
6. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
[TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
[TBL] [Abstract][Full Text] [Related]
9. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
[TBL] [Abstract][Full Text] [Related]
10. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
11. Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma.
Tan SH; Ida H; Goh BC; Hsieh W; Loh M; Ito Y
Anticancer Res; 2006; 26(6B):4287-92. PubMed ID: 17201146
[TBL] [Abstract][Full Text] [Related]
12. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].
Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT
Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
14. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.
Yi Lo PH; Chung Leung AC; Xiong W; Law S; Duh FM; Lerman MI; Stanbridge EJ; Lung ML
Cancer Lett; 2006 Mar; 234(2):184-92. PubMed ID: 15885884
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
19. Differential gene methylation in undifferentiated nasopharyngeal carcinoma.
Wong TS; Tang KC; Kwong DL; Sham JS; Wei WI; Kwong YL; Yuen AP
Int J Oncol; 2003 Apr; 22(4):869-74. PubMed ID: 12632081
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]